This article has been cited by
1Epidemiological and Economic Evaluation of a Pilot Prostate Cancer Screening Program
Dariga S. Smailova,Elisa Fabbro,Serik E. Ibrayev,Luca Brusati,Yuliya M. Semenova,Umutzhan S. Samarova,Farida S. Rakhimzhanova,Sabit M. Zhussupov,Zaituna A. Khismetova,Hengameh Hosseini
Prostate Cancer.2020;2020()1
[DOI]
2PI-RADS version 2.1 scoring system is superior in detecting transition zone prostate cancer: a diagnostic study
Zhibing Wang,Wenlu Zhao,Junkang Shen,Zhen Jiang,Shuo Yang,Shuangxiu Tan,Yueyue Zhang
Abdominal Radiology.2020;45(12)4142
[DOI]
3Total thiol can contribute to differentiating prostate cancer from BPH: Prostate Thiol Index as a new player
Medeni Arpa,Bayram Sen,Huseyin Eren,Hakki Uzun,Oguzhan Okcu,Ozcan Erel
Andrologia.2021;45(12)4142
[DOI]
4Immunohistochemical investigation of cytokine expression levels as biomarkers in transrectal ultrasound-guided needle biopsy specimens of prostate adenocarcinoma
Jagtar Singh,Thanuja Thachil,Mathew Eapen,Aijye Lim,Wajiha Sufyan,Robert Rawson,Henry Duncan,Paolo De Ieso,Sukhwinder Sohal
Molecular and Clinical Oncology.2021;15(3)4142
[DOI]
5Improving the detection rate of prostate cancer in the gray zone of PI-RADS v2 and serum tPSA by using prostate-specific antigen–age volume
Yuan-Fei Lu,Qian Zhang,Hai-Yan Chen,Jie-Yu Chen,Yao Pan,Cong-Cong Xu,Jian-Xia Xu,Ri-Sheng Yu
Medicine.2019;98(26)e16289
[DOI]
Feedback

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal